Artal Group »

Portage Fintech Acq -cw23 shares owned by Artal Group

Quarter-by-quarter ownership of Portage Fintech Acq -cw23 (PFTAW) shares owned by Artal Group from 13F filings

Historical chart of Artal Group investment in Portage Fintech Acq -cw23

Tip: Access up to 7 years of quarterly data

All positions including Portage Fintech Acq -cw23 held by Artal Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Portage Fintech Acq -cw23 by Artal Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $3.5k 127k 0.03

More positions owned by Artal Group

Cava Group Ord (CAVA)
Lexicon Pharmaceuticals Com New (LXRX)
Arrowhead Pharmaceuticals Call Option (ARWR)
Scholar Rock Hldg Corp (SRRK)
Kymera Therapeutics (KYMR)
Morphic Hldg (MORF)
Apellis Pharmaceuticals (APLS)
Dyne Therapeutics (DYN)
Silence Therapeutics Ads (SLN)
Springworks Therapeutics (SWTX)
Crinetics Pharmaceuticals In (CRNX)
Merus N V (MRUS)
Beigene Sponsored Adr (BGNE)
Revolution Medicines (RVMD)
Kura Oncology (KURA)

View all positions for Artal Group

Top funds holding Portage Fintech Acq -cw23

Periscope Capital
Security Benefit Life Insurance
Dryden Capital
Polar Securities
Highbridge Capital Management
K2 Principal Fund
Millennium Management
Saba Capital Management
Vestcor Investment Management Corp
Calamos Advisors
Artal Group
Clear Street
Kim
CNH Partners
Healthcare Of Ontario Pension Plan Trust Fund

View all funds holding Portage Fintech Acq -cw23